Medical School News and Research

RSS

Study reveals safety of second mRNA COVID-19 vaccine dose after allergic reactions to first dose

In a multi-hospital analysis of individuals who experienced an allergic reaction to their first mRNA COVID-19 vaccine dose, all patients who went on to receive a second dose tolerated it without complications.

26 Jul 2021

Mount Sinai researchers use cerebral organoids to study frontotemporal dementia

Frontotemporal dementias are a group of fatal and debilitating brain disorders for which there are no cures.

26 Jul 2021

Nasal swabs reveal muted antiviral response in patients who developed severe COVID-19

Over the past 18 months, researchers have learned much about COVID-19 and its viral cause, SARS-CoV-2. They know how the virus enters the body, coming in through the nose and mouth and beginning its infection in the mucus layers of the nasal passageway.

26 Jul 2021

ASCCP voices support for 2020 ACS guidelines, recognizes the need to shift to primary HPV screening

Last year, the American Cancer Society (ACS) issued an updated set of guidelines for cervical cancer screening - emphasizing the shift toward screening with primary human papillomavirus (HPV) testing.

26 Jul 2021

Novel atlas charts how different antibodies attack a major piece of SARS-CoV-2 machinery

As the SARS-CoV-2 virus that causes COVID-19 continues to evolve, immunologists and infectious diseases experts are eager to know whether new variants are resistant to the human antibodies that recognized initial versions of the virus.

26 Jul 2021

Novel therapeutic agent could be effective for treating cancers with certain gene mutations

Mount Sinai researchers have developed a therapeutic agent that shows high effectiveness in vitro at disrupting a biological pathway that helps cancer survive, according to a paper published in Cancer Discovery, a journal of the American Association for Cancer Research, in July.

23 Jul 2021

Better healthcare processes can reduce the risk of delirium among elderly patients

Elderly patients with neurological conditions are significantly more likely to develop delirium shortly after they are hospitalized.

23 Jul 2021

MUSC Hollings Cancer Center part of promising phase 2 lymphoma clinical trial

MUSC Hollings Cancer Center was one of 28 clinical sites around the world that participated in the LOTIS-2 trial to test the efficacy of Loncastuximab tesirine, a promising new treatment for aggressive B-cell lymphoma.

23 Jul 2021

Blunted antiviral responses in the nasopharynx may underlie severe COVID-19

The body's first encounter with SARS-CoV-2, the virus behind COVID-19, happens in the nose and throat, or nasopharynx. A new study in the journal Cell suggests that the first responses in this battleground help determine who will develop severe disease and who will get through with mild or no illness.

23 Jul 2021

Facing headwinds on new Alzheimer’s drug, Biogen launches controversial campaign

Do you sometimes lose your train of thought or feel a bit more anxious than is typical for you?

23 Jul 2021

Scientists design a tougher, safer bicycle helmet using a combination of materials

As cities worldwide expand their networks of cycling paths and more cyclists take to the streets, the chances of cycling accidents and potential collisions increase as well, underscoring the need for proper cycling safety in dense urban areas.

23 Jul 2021

Investigational antipsychotic treatment offers sustained benefits for people with dementia-related psychosis

Evidence of the sustained benefits of an investigational antipsychotic treatment for people with dementia-related psychosis has been published.

22 Jul 2021

Study reveals calcium's role in directing blood flow in the brain

Unlike the rest of the body, there is not enough real estate in the brain for stored energy. Instead, the brain relies on the hundreds of miles of blood vessels within it to supply fresh energy via the blood. Yet, how the brain expresses a need for more energy during increased activity and then directs its blood supply to specific hot spots was, until now, poorly understood.

22 Jul 2021

Structural home repairs in low-income neighborhoods linked with reduced crime rates

Investing in structural home repairs in historically segregated, low-income, Black, and Latino neighborhoods have been associated with reduced crime rates.

22 Jul 2021

Study lays out challenges of achieving equity in communication for diverse patients at hospital discharge

A new study by research, quality improvement and health equity experts at Massachusetts General Hospital in The American Journal of Managed Care lays out the challenges of achieving equity for diverse patients in communication at hospital discharge.

21 Jul 2021

Clinical trial to test personalized treatment for severe asthma caused by a specific mutation

Under a $10 million grant, a randomized, placebo-controlled clinical trial led by Boston Children's Hospital will test a personalized treatment for a form of severe asthma to which Black and Latinx children and adults are especially vulnerable.

21 Jul 2021

Study evaluates physical activity and sedentary behavior in relation to OSA risk

Being more physically active and spending fewer hours per day sitting watching TV is linked to a substantially lower risk of developing obstructive sleep apnea (OSA), according to new research published in the European Respiratory Journal

21 Jul 2021

Global consortium publishes findings on all-cause mortality during COVID-19 pandemic in 22 countries

A global consortium representing 27 institutions has published findings comparing mortality in the previous five years to deaths between January and August 2020 in the first wave of the pandemic.

21 Jul 2021

Protein involved in cell migration offers clues to cancer metastases

A protein involved in making cells move offers a clue to how certain types of cancer metastasize and develop into secondary tumors, according to new research from the University of Warwick.

21 Jul 2021

Analysis: Necessary or not, covid booster shots are probably on the horizon

The drugmaker Pfizer recently announced that vaccinated people are likely to need a booster shot to be effectively protected against new variants of covid-19 and that the company would apply for Food and Drug Administration emergency use authorization for the shot.

21 Jul 2021

Medical School News and Research

Study reveals safety of second mRNA COVID-19 vaccine dose after allergic reactions to first dose

Mount Sinai researchers use cerebral organoids to study frontotemporal dementia

Nasal swabs reveal muted antiviral response in patients who developed severe COVID-19

ASCCP voices support for 2020 ACS guidelines, recognizes the need to shift to primary HPV screening

Novel atlas charts how different antibodies attack a major piece of SARS-CoV-2 machinery

Novel therapeutic agent could be effective for treating cancers with certain gene mutations

Better healthcare processes can reduce the risk of delirium among elderly patients

MUSC Hollings Cancer Center part of promising phase 2 lymphoma clinical trial

Blunted antiviral responses in the nasopharynx may underlie severe COVID-19

Facing headwinds on new Alzheimer’s drug, Biogen launches controversial campaign

Scientists design a tougher, safer bicycle helmet using a combination of materials

Investigational antipsychotic treatment offers sustained benefits for people with dementia-related psychosis

Study reveals calcium's role in directing blood flow in the brain

Structural home repairs in low-income neighborhoods linked with reduced crime rates

Study lays out challenges of achieving equity in communication for diverse patients at hospital discharge

Clinical trial to test personalized treatment for severe asthma caused by a specific mutation

Study evaluates physical activity and sedentary behavior in relation to OSA risk

Global consortium publishes findings on all-cause mortality during COVID-19 pandemic in 22 countries

Protein involved in cell migration offers clues to cancer metastases

Analysis: Necessary or not, covid booster shots are probably on the horizon

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News